Vimarsana
Biggest News Aggregation in the World

Page 5 - Nat Commun News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nat Commun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nat Commun Today - Breaking & Trending Today

Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board - Vimarsana News

Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board

/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today...

Echoes of extinctions: novel method unearths - Vimarsana News

Echoes of extinctions: novel method unearths

New research from the Georgia Institute of Technology explores the historical shifts in mammal traits and biodiversity loss in eastern Africa. The study reveals how environmental changes disrupted mammal communities and highlights the urgent need for targeted conservation efforts to protect vulnerable species.

Mathematics formula K-Theory used to advance understanding of topological materials - Vimarsana News

Mathematics formula K-Theory used to advance understanding of topological materials

Terry Loring, distinguished professor of Mathematics and Statistics, recently published and co-authored a new research piece involving his research on K-theory with the major advances in applications to critical problems in physics. The new research...

Source: unm.edu
Elicio Therapeutics Reports Second Quarter 2023 Financial - Vimarsana News

Elicio Therapeutics Reports Second Quarter 2023 Financial

ELI-002 2P positive interim data from AMPLIFY-201 Phase 1 study presented at ASCOAMPLIFY-7P first patient dosed with ELI-002 7P Completed reverse merger...

Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updates - Vimarsana News

Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

ELI-002 2P positive interim data from AMPLIFY-201 Phase 1 study presented at ASCOAMPLIFY-7P first patient dosed with ELI-002 7P Completed reverse merger becoming a publicly traded company on Nasdaq...